Healthcare

  • Brexit & health: patience needed

    Discussing Brexit and its impact on the healthcare sector is a risky exercise, especially in the current rather blurred context. The UK Prime Minister, Theresa May, already under fire for failing to grasp the scale of the challenge facing the National Health Service (NHS), recently scrapped a high-level task force working on the issue. If…

  • mHealth’s time is now!

    “It’s time to seize the potential of mHealth”. This was the clear message of yesterday’s hearing on mHealth in the European Parliament. Commissioner Andriukaitis, Members of the European Parliament Peterle and Boni and participants all agreed that mHealth, and in particular health apps, have the power to transform the relationship between patients and doctors. Speakers…

  • UN Panel on Access to Medicines: What’s the impact on the pharmaceutical market?

    Following several months of intense discussion and negotiations, the High-Level Panel on Access to Medicines has published its report today. The 15 members of the panel, representing a wide range of experts and stakeholders in the health innovation area, have not found consensus on remedies to change the current IP system for medicines, but agreed…

  • ROBOTICS AND HEALTHCARE: Is the EU rising to the Opportunities and Threats?

    Technology is rapidly transforming the healthcare sector as we know it. While it is generally accepted that eHealth and mHealth can improve citizens’ possibility to monitor and evaluate their health, there is less knowledge about the wide range of uses of robotics in healthcare  – from  service robots in hospitals who deliver bed-linen and retrieve…

  • Brexit’s Impact on Healthcare and Life Sciences

    Health and life sciences are heavily regulated sectors, which directly employ a significant proportion of the workforce across health and care delivery, pharmaceuticals, research and development, education, animal health and the many other issues covered by the sector. The sector drives a significant percentage of trade inside and outside the EU market and healthcare consumes,…

  • Another call for action on the fight against AMR

    Last week, the Review on Antimicrobial Resistance, published its final report on Tackling Drug-Resistant Infections Globally. The document represents an important call for action in the global fight against AMR and is expected to have a huge impact on the current debate. Setting the scene, the report states that 700,000 people die of drug-resistant infections…

  • First steps taken but still a long way to go to tackle antimicrobial resistance

    Last week, the European Parliament adopted its report on veterinary medicinal products advocating for the banning of collective and preventive antibiotic treatment of animals. The vote represents an important step in the fight against antimicrobial resistance (AMR) in Europe and Commissioner Andriukaitis strongly welcomed the EP report and the good work of Rapporteur, Mrs Grossetête.…

  • Meeting the challenges of patents, innovation and access to global health

    Over the past years, and as a response to the financial crisis in Europe, the pharmaceutical sector has felt the squeeze of cuts in healthcare spending. Not only have pharmaceutical companies had to re-adjust to the new market conditions, they have also been under the close scrutiny of the European Commission amidst claims of excessive…

  • German e-health law – a breakthrough for the digital health sector?

    Digitisation has become a political buzzword in Germany, raising particular concerns with regard to the German healthcare system. German politics has long been lagging behind in creating an appropriate framework that balances health benefits versus data protection issues. Now a new e-health law about to be passed, triggering a dynamic debate on digitisation, data and health.…

  • Medical Device Directive: state of play and future challenges

    The European Institutions have been working on the Directive on Medical Devices and In-Vitro Diagnostics since 2012. With the adoption of the European Parliament’s position in 2013 and the Council agreeing their approach in October 2015, the process has undoubtedly been slow. It was originally hoped that a conclusion would be finally reached by Christmas…

Back to top